The Latest Cardiac and Vascular News
Birmingham, Alabama – April 24, 2025 – Rampart IC, a medical technology company developing market leading radiation safety and orthopedic protection solutions for the interventional suite, today announced the successful completion of its $21.6M Series B financing round. The round was led by Vensana Capital, a leading venture capital firm […]
ew investment fuels growth of ECG-AI platform and development of perioperative AI capabilities CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, a leading AI-driven health technology company, has expanded beyond its diagnostic ECG-AI™ technology into perioperative and acute cardiac care. The company recently brought on Boston Scientific Corporation as a new investor in its Series […]
Vbeam Pro will be unveiled at the 2025 Annual Meeting of American Society for Laser Medicine and Surgery (ASLMS) MARLBOROUGH, Mass., April 24, 2025 /PRNewswire/ — Candela Corporation, a global leader in energy-based medical aesthetics, proudly announced the launch of the Vbeam Pro…
Published in the International Journal of Cardiology, new study demonstrates 91.6% accuracy and introduces the HF-index for on-demand severity tracking TOKYO, April 24, 2025 /PRNewswire/ — Simplex Quantum, in collaboration with the University of Tokyo Hospital, today announced the…
DENVER, April 24, 2025 /PRNewswire/ — CardioOne, a national growth and operational partner supporting independent cardiology practices, today announced the acquisition of CardioDiagnostics, an advanced cardiac monitoring platform. This acquisition marks a major strategic milestone,…
THE WOODLANDS, TX, April 24, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced its technology and early proof-of-concept study results will be featured in a poster presentation as part of PCR Innovators Day at the world-leading course in interventional cardiovascular medicine, EuroPCR, being held May 20-23, 2025 in Paris, France.
Comprehensive analysis of real-world data shows significant clinical and medico-economic advantages of Implicity’s universal, alert-based remote monitoring platform CAMBRIDGE, Mass., April 24, 2025 /PRNewswire/ — IMPLICITY®, a leader in remote patient monitoring and cardiac data…
– Topline results expected in Q3 2025 – SOUTHLAKE, Texas, April 24, 2025 /PRNewswire/ — Renibus Therapeutics® (“Renibus”), a clinical late-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and metabolic diseases, today announced the completion of…
– Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month – KYOTO, Japan, April 24, 2025 /PRNewswire/ — OMRON Healthcare Co., Ltd. (Head Office: Muko, Kyoto Prefecture; hereinafter…
Budiodarone shown in Phase 2 to reduce atrial fibrillation symptoms and long episodes of atrial fibrillation (LEAF) FDA gives guidance on steps necessary to gain approval and incorporate wearable AF monitoring devices into label for budiodarone Five granted US patents align with FDA’s…
